Since the discovery of the first genes associated with hereditary monogenic cardiovascular diseases (CVD) in the early and mid-1990s, genetic testing for familial aortic diseases, cardiomyopathies, cardiac channelopathies, and hypercholesterolemia has rapidly evolved from an initial research effort into a suite of genetically tested conditions that are now commercially available and covered by insurance (Lebo and Baxter 2014). Collectively, genetic testing for rare monogenic CVDs, the ongoing development of genetic risk scores for common polygenic CVDs, and the implementation of pharmacogenomic tests to predict response to cardiovascular drugs represent the spectrum of genetic tests that currently impact the diagnosis, risk stratification, and clinical monitoring/treatment of patients with CVD. For many of these heart diseases, there are medical recommendations for genetic testing, which is considered an important component in the clinical management of both affected individuals and their family members.
Hypertrophic Cardiomyopathy (HCM), a disease of the heart muscle characterized by asymmetric or symmetric left ventricular hypertrophy (LVH), is the most common cause of sudden death in young people, with a global prevalence of 1 in 500. More than 20 genes are involved in this disease, making NGS (Next-Generation Sequencing) panels effective methods for studying it.
The benefits of genetic testing include:
- Early identification of asymptomatic carriers who require periodic cardiovascular screening and reduction of anxiety in family members who do not have an increased risk;
- Confirmation of the clinical diagnosis of HCM and differentiation from other causes, allowing for the targeting of: a) treatment; b) preventive measures (e.g., implantable cardiac defibrillators or pharmacological prophylaxis); and monitoring (periodic assessment of the risk of sudden cardiac death) c) implementation of risk-reduction behaviors (e.g., restrictions on medications and physical activities);
- Family and career planning.
If you have any questions, please contact us.
We'll be happy to help.
CLINICAL PATHOLOGY LABORATORY
